Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Greg Jung who wrote (1222)	3/4/2000 5:13:00 PM
From: William Strop	Read Replies (2) \| Respond to of 1972

Greg, I agree with your view. The FDA has to be concerned after the PA. death, step up monitoring, etc..., otherwise they aren't doing their job. Regarding that subject, the WSJ (Friday, 3/3/2000) has an article re: the Vascular Genetics trials. Good reading for everyone with quotes from Vascular Genetics & Human Genome Sciences. Jeffrey Isner, chief researcher, was quoted as saying, "I am looking forward to the opportunity to present the results of these trials in two weeks, and at that time I believe the safety & efficacy will be more than apparent". I think he will be reporting sometime the week of 3/12/2000. Bill

To: Greg Jung who wrote (1222)	3/7/2000 9:05:00 PM
From: David Bogdanoff	Read Replies (2) \| Respond to of 1972

GJ; Can you provide a link and/or details on these unreported gene therapy deaths? TIA. David

To: Greg Jung who wrote (1222)	3/8/2000 5:35:00 PM
From: tonyt	Respond to of 1972

>It is the human gene therapy experiments themselves that are getting closer scrutiny, >after several unreported deaths. >Nothing to do with naked delivery. The article, while having no mention of Vical, does refer to 'naked dna' ("Unlike the Penn study, which used potentially toxic viruses to deliver new genes to patients, Isner's studies infused raw, or "naked" DNA into patients' vessels.") I don't know what connection, if any, this would have with Vical. For the full article see "FDA Stops Researcher's Human Gene Therapy Experiments (washingtonpost.com) washingtonpost.com